Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study
- 17 February 2025
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (7) , 1183-1196
Abstract
Background: Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for managing portal hypertension in cirrhotic patients, but the impact of post‐TIPS overt hepatic encephalopathy (OHE) on survival remains controversial. While its effect on short‐term survival is well‐documented, its long‐term implications remain unclear.Aims: This study aims to investigate the long‐term impact of post‐TIPS OHE on mortality in cirrhotic patients for variceal bleeding, focusing on the timing and predictive value of OHE beyond the first year post‐TIPS.Methods: A multicenter, retrospective cohort study was conducted involving 3262 cirrhotic patients who underwent TIPS for variceal bleeding at seven Chinese tertiary centers between January 2010 and June 2020. Clinical data, including demographics, procedure details, post‐TIPS complications and survival outcomes, were collected. The primary endpoints were all‐cause mortality and OHE, with follow‐up until death, liver transplantation or 60 months. Propensity score matching minimised confounding effects, and multivariate Fine‐Grey competing risk models identified independent mortality predictors.Results: During a median follow‐up of 1077 days, 33.2% developed post‐TIPS OHE, associated with higher MELD and Child‐Pugh scores. Among these, 19.3% died, with a median time from OHE onset to death of 947 days. Post‐TIPS OHE was not linked to early survival (within 12 months) but emerged as an independent predictor of long‐term mortality beyond 24 months, consistent across various clinical scenarios.Conclusion: Post‐TIPS OHE does not affect short‐term survival but significantly increases long‐term mortality risk. These findings highlight the need for continuous monitoring and tailored interventions to improve long‐term outcomes in post‐TIPS patients.Keywords
Funding Information
- Jiangsu Provincial Key Research and Development Program (BE2023767)
- National Key Research and Development Program of China (2023YFC2507500)
This publication has 47 references indexed in Scilit:
- Thirty years' transjugular intrahepatic portosystemic stent‐shunt (TIPS) in China: Opportunities and challengesPortal Hypertension & Cirrhosis, 2022
- Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomesInternal and Emergency Medicine, 2020
- Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic ShuntAcademic Radiology, 2019
- Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational StudyHepatology, 2018
- Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt PlacementClinical Gastroenterology and Hepatology, 2017
- Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysisHepatology, 2016
- Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic EncephalopathyClinical Gastroenterology and Hepatology, 2014
- Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the LiverHepatology, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Right Atrial Pressure Is Not Adequate to Calculate Portal Pressure Gradient in Cirrhosis: A Clinical-Hemodynamic Correlation StudyHepatology, 2010